RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Maybe partnerships are coming soonI agree they have started attending more conferences but as per Spceo I also would like to see them utilizing more retail oriented platforms like fire chat, drbeen.. so they get a balanced exposure among both institutional and retail investors. Institutions and their clients surely can increase the demand same applies to retail investors.
Wino115 wrote: I do believe this will change -- Conferences, AACR, maybe some of that data Qwerty speculated about the other day (?), first dose into human, safety, POC, etc... We're all upset that this didn't participate and we could have used the money elsewhere and done quite well with all sorts of other investments. I'm hopeful this year will be their year in the sun when others are getting stalled out given 2020 returns. Hard Data in Humans! We need it.
scarlet1967 wrote: My problem is TH never participated in the rally , they came out with NASH hiv followed by many encouraging preclinical oncology results followed by new skillful CEO followed by general NASH followed by record breaking sales and FDA's letters study may proceed for both programs etc .yet they are following the pack loosing "market valuation" which never gained any traction during the bull market despite all the catalysts/progresses. They have achieved many milestones and failed so far on one milestone which is selling the company to the market.
Other companies have produced less good results but managed to get credit for the little things they have done which is the opposite scenario where TH has so far done.
They need to understand regardless where you are in your process you need to promote it because otherwise other companies will run you over, rub your audience and leave you with left overs.
juniper88 wrote: Bucknelly21 wrote: Well wino there's the sub three you were worried about....
The TSX Venture index is down over 6% today, similar to yesterday.
So, companies like TH are down...